- Issuer ticker
-
HUMA
- Reported as of
-
11 Jun 2026
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
12 Jun 2026, 17:57:52 UTC
Filing notes and source
Key filing fact
Laura E. Niklason filed Form 4 for Humacyte, Inc. (HUMA) on 12 Jun 2026.
Key facts
- This page summarizes Laura E. Niklason's Form 4 filing for Humacyte, Inc. (HUMA).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 12 Jun 2026, 17:57.
Change
- Previous filing in this sequence was filed on 17 Nov 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001878075
Primary reporting owner
Niklason Laura E
- Relationship
-
President, CEO and Director, Director
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HUMA
transaction
Derivative
Stock Options (right to buy)
Award
- Transaction value
- Shares
- +80,000
- Change %
- Price
-
$0.000000*
- Shares after
- 80,000
- Date
- 11 Jun 2026
- Ownership
- By spouse
- Underlying class
- Common Stock
- Underlying amount
- 80,000
- Exercise price
- $1.08
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote